17-alpha-Hydroxyprogesterone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Hydroxyprogesterone caproate.
Abiraterone
The metabolism of Gliclazide can be decreased when combined with Abiraterone.
Acarbose
Acarbose may increase the hypoglycemic activities of Gliclazide.
Advertisement
Acebutolol
Acebutolol may increase the hypoglycemic activities of Gliclazide.
Acenocoumarol
Gliclazide may increase the anticoagulant activities of Acenocoumarol.
Acetohexamide
Acetohexamide may increase the hypoglycemic activities of Gliclazide.
Advertisement
Acetyl salicylate
Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.
Albiglutide
Albiglutide may increase the hypoglycemic activities of Gliclazide.
Alogliptin
Alogliptin may increase the hypoglycemic activities of Gliclazide.
Advertisement
Aloxiprin
Aloxiprin may increase the hypoglycemic activities of Gliclazide.
Alprenolol
Alprenolol may increase the hypoglycemic activities of Gliclazide.
Aminosalicylic Acid
Aminosalicylic Acid may increase the hypoglycemic activities of Gliclazide.
Amiodarone
The metabolism of Gliclazide can be decreased when combined with Amiodarone.
Amphetamine
Amphetamine may increase the hypoglycemic activities of Gliclazide.
Anhydrous Tacrolimus
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Tacrolimus.
Apalutamide
The serum concentration of Gliclazide can be decreased when it is combined with Apalutamide.
Aprepitant
The metabolism of Gliclazide can be increased when combined with Aprepitant.
Aripiprazole
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Aripiprazole.
Armodafinil
The metabolism of Gliclazide can be decreased when combined with Armodafinil.
Arsenic Trioxide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Arsenic trioxide.
Articaine
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Articaine.
Asenapine
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Asenapine.
Aspirin
Acetylsalicylic acid may increase the hypoglycemic activities of Gliclazide.
Atazanavir
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Atazanavir.
Atenolol
Atenolol may increase the hypoglycemic activities of Gliclazide.
Atorvastatin
Atorvastatin may increase the hypoglycemic activities of Gliclazide.
Balsalazide
Balsalazide may increase the hypoglycemic activities of Gliclazide.
Bendroflumethiazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Bendroflumethiazide.
Betamethasone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Betamethasone.
Betaxolol
Betaxolol may increase the hypoglycemic activities of Gliclazide.
Bezafibrate
Bezafibrate may increase the hypoglycemic activities of Gliclazide.
Bisoprolol
Bisoprolol may increase the hypoglycemic activities of Gliclazide.
Bopindolol
Bopindolol may increase the hypoglycemic activities of Gliclazide.
Bortezomib
The metabolism of Gliclazide can be decreased when combined with Bortezomib.
Brexpiprazole
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Brexpiprazole.
Bumetanide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Bumetanide.
Bupranolol
Bupranolol may increase the hypoglycemic activities of Gliclazide.
Buserelin
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Buserelin.
Canagliflozin
Canagliflozin may increase the hypoglycemic activities of Gliclazide.
Canagliflozin Anhydrous
Canagliflozin may increase the hypoglycemic activities of Gliclazide.
Capecitabine
The metabolism of Gliclazide can be decreased when combined with Capecitabine.
Carbamazepine
The metabolism of Gliclazide can be increased when combined with Carbamazepine.
Carbocysteine
The risk or severity of adverse effects can be increased when Gliclazide is combined with Carbocisteine.
Carteolol
Carteolol may increase the hypoglycemic activities of Gliclazide.
Carvedilol
Carvedilol may increase the hypoglycemic activities of Gliclazide.
Celiprolol
Celiprolol may increase the hypoglycemic activities of Gliclazide.
Ceritinib
The serum concentration of Gliclazide can be increased when it is combined with Ceritinib.
Chloramphenicol
The metabolism of Gliclazide can be decreased when combined with Chloramphenicol.
Chlorothiazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Chlorothiazide.
Chlorpropamide
Chlorpropamide may increase the hypoglycemic activities of Gliclazide.
Chlorthalidone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Chlorthalidone.
Cholecalciferol
The metabolism of Gliclazide can be decreased when combined with Cholecalciferol.
Cilostazol
The serum concentration of Cilostazol can be increased when it is combined with Gliclazide.
Cimetidine
The serum concentration of Gliclazide can be increased when it is combined with Cimetidine.
Cinoxacin
Cinoxacin may increase the hypoglycemic activities of Gliclazide.
Ciprofibrate
Ciprofibrate may increase the hypoglycemic activities of Gliclazide.
Citalopram
The metabolism of Gliclazide can be decreased when combined with Citalopram.
Clofibrate
Clofibrate may increase the hypoglycemic activities of Gliclazide.
Clotrimazole
The metabolism of Gliclazide can be decreased when combined with Clotrimazole.
Clozapine
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Clozapine.
coenzyme Q10
The therapeutic efficacy of Gliclazide can be increased when used in combination with Ubidecarenone.
Corticotropin
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Corticotropin.
Cortisone Acetate
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Cortisone acetate.
Crisaborole
The metabolism of Gliclazide can be decreased when combined with Crisaborole.
Cyclopenthiazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Cyclopenthiazide.
Cyclosporine
The metabolism of Gliclazide can be decreased when combined with Cyclosporine.
Cyproterone Acetate
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Cyproterone acetate.
Dabrafenib
The serum concentration of Gliclazide can be decreased when it is combined with Dabrafenib.
Danazol
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Danazol.
Darunavir
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Darunavir.
Delavirdine
The metabolism of Gliclazide can be decreased when combined with Delavirdine.
Desogestrel
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Desogestrel.
Desvenlafaxine
Desvenlafaxine may increase the hypoglycemic activities of Gliclazide.
Dexamethasone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Dexamethasone.
Diazoxide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Diazoxide.
Dicumarol
Gliclazide may increase the anticoagulant activities of Dicoumarol.
Dienogest
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Dienogest.
Diflunisal
Diflunisal may increase the hypoglycemic activities of Gliclazide.
Disopyramide
Disopyramide may increase the hypoglycemic activities of Gliclazide.
Dothiepin
The metabolism of Gliclazide can be decreased when combined with Dosulepin.
Drospirenone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Drospirenone.
Dulaglutide
Dulaglutide may increase the hypoglycemic activities of Gliclazide.
Duloxetine
Duloxetine may increase the hypoglycemic activities of Gliclazide.
Efavirenz
The metabolism of Gliclazide can be decreased when combined with Efavirenz.
Empagliflozin
Empagliflozin may increase the hypoglycemic activities of Gliclazide.
Enoxacin
Enoxacin may increase the hypoglycemic activities of Gliclazide.
Epinephrine
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Epinephrine.
Ertugliflozin
Ertugliflozin may increase the hypoglycemic activities of Gliclazide.
Escitalopram
Escitalopram may increase the hypoglycemic activities of Gliclazide.
Eslicarbazepine Acetate
The metabolism of Gliclazide can be decreased when combined with Eslicarbazepine acetate.
Esmolol
Esmolol may increase the hypoglycemic activities of Gliclazide.
Esomeprazole
The metabolism of Gliclazide can be decreased when combined with Esomeprazole.
Estradiol
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Estradiol.
Ethacrynate
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Etacrynic acid.
Ethacrynic Acid
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Etacrynic acid.
Ethanol
The risk or severity of adverse effects can be increased when Gliclazide is combined with Ethanol.
Ethinyl Estradiol
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Ethinyl Estradiol.
Ethynodiol Diacetate
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Ethynodiol diacetate.
Etofibrate
Etofibrate may increase the hypoglycemic activities of Gliclazide.
Etonogestrel
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Etonogestrel.
Etravirine
The metabolism of Gliclazide can be decreased when combined with Etravirine.
Everolimus
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Everolimus.
Exenatide
Exenatide may increase the hypoglycemic activities of Gliclazide.
Fenofibrate
Fenofibrate may increase the hypoglycemic activities of Gliclazide.
Fenofibric Acid
Fenofibric acid may increase the hypoglycemic activities of Gliclazide.
Fleroxacin
Fleroxacin may increase the hypoglycemic activities of Gliclazide.
Floxuridine
The metabolism of Gliclazide can be decreased when combined with Floxuridine.
Fluconazole
The serum concentration of Gliclazide can be increased when it is combined with Fluconazole.
Fludrocortisone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Fludrocortisone.
Fluindione
Gliclazide may increase the anticoagulant activities of Fluindione.
Flumequine
Flumequine may increase the hypoglycemic activities of Gliclazide.
Fluorouracil
The metabolism of Gliclazide can be decreased when combined with Fluorouracil.
Fluoxetine
The metabolism of Gliclazide can be decreased when combined with Fluoxetine.
Fluoxymesterone
Fluoxymesterone may increase the hypoglycemic activities of Gliclazide.
Fluvastatin
The metabolism of Gliclazide can be decreased when combined with Fluvastatin.
Fluvoxamine
The metabolism of Gliclazide can be decreased when combined with Fluvoxamine.
Fosamprenavir
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Fosamprenavir.
Fosphenytoin
The metabolism of Gliclazide can be increased when combined with Fosphenytoin.
Furazolidone
Furazolidone may increase the hypoglycemic activities of Gliclazide.
Furosemide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Furosemide.
Gatifloxacin
Gatifloxacin may increase the hypoglycemic activities of Gliclazide.
Gatifloxacin Anhydrous
Gatifloxacin may increase the hypoglycemic activities of Gliclazide.
Gemfibrozil
The metabolism of Gliclazide can be decreased when combined with Gemfibrozil.
Gemifloxacin
Gemifloxacin may increase the hypoglycemic activities of Gliclazide.
Gemifloxacin Mesylate
Gemifloxacin may increase the hypoglycemic activities of Gliclazide.
Glibornuride
Glibornuride may increase the hypoglycemic activities of Gliclazide.
Glimepiride
Glimepiride may increase the hypoglycemic activities of Gliclazide.
Glipizide
Glipizide may increase the hypoglycemic activities of Gliclazide.
Gliquidone
Gliquidone may increase the hypoglycemic activities of Gliclazide.
Glyburide
Glyburide may increase the hypoglycemic activities of Gliclazide.
Goserelin
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Goserelin.
Grepafloxacin
Grepafloxacin may increase the hypoglycemic activities of Gliclazide.
Histrelin
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Histrelin.
Hydrochlorothiazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Hydrochlorothiazide.
Hydrocortisone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Hydrocortisone.
Hydroflumethiazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Hydroflumethiazide.
hydroxyprogesterone caproate (USP)
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Hydroxyprogesterone caproate.
Iloperidone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Iloperidone.
Indapamide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Indapamide.
Indinavir
The metabolism of Gliclazide can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Gliclazide can be decreased when combined with Indinavir.
Insulin Detemir
Gliclazide may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Insulin Glargine may increase the hypoglycemic activities of Gliclazide.
insulin human, rDNA origin
Insulin Human may increase the hypoglycemic activities of Gliclazide.
Insulin Lispro
Insulin Lispro may increase the hypoglycemic activities of Gliclazide.
Insulin, Aspart Protamine, Human
Gliclazide may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Gliclazide may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Gliclazide may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Pork
Insulin Pork may increase the hypoglycemic activities of Gliclazide.
Insulin, Protamine Lispro, Human
Insulin Lispro may increase the hypoglycemic activities of Gliclazide.
Insulin, Regular, Pork
Insulin Pork may increase the hypoglycemic activities of Gliclazide.
Iproniazid
Iproniazid may increase the hypoglycemic activities of Gliclazide.
Irbesartan
The metabolism of Gliclazide can be decreased when combined with Irbesartan.
Isocarboxazid
Isocarboxazid may increase the hypoglycemic activities of Gliclazide.
Isoniazid
The metabolism of Gliclazide can be decreased when combined with Isoniazid.
Ketoconazole
The metabolism of Gliclazide can be decreased when combined with Ketoconazole.
Labetalol
Labetalol may increase the hypoglycemic activities of Gliclazide.
Lanreotide
Gliclazide may increase the hypoglycemic activities of Lanreotide.
Leflunomide
The metabolism of Gliclazide can be decreased when combined with Leflunomide.
Leuprolide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Leuprolide.
Levobunolol
Levobunolol may increase the hypoglycemic activities of Gliclazide.
Levofloxacin
Levofloxacin may increase the hypoglycemic activities of Gliclazide.
Levofloxacin Anhydrous
Levofloxacin may increase the hypoglycemic activities of Gliclazide.
Levomilnacipran
Levomilnacipran may increase the hypoglycemic activities of Gliclazide.
Levonorgestrel
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Levonorgestrel.
Linagliptin
Linagliptin may increase the hypoglycemic activities of Gliclazide.
Liraglutide
Liraglutide may increase the hypoglycemic activities of Gliclazide.
Lopinavir
The metabolism of Gliclazide can be increased when combined with Lopinavir.
Losartan
The metabolism of Gliclazide can be decreased when combined with Losartan.
Lovastatin
The metabolism of Gliclazide can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Gliclazide can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Gliclazide can be decreased when it is combined with Lumacaftor.
Lurasidone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Lurasidone.
Manidipine
The metabolism of Gliclazide can be decreased when combined with Manidipine.
Mecasermin
Gliclazide may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Gliclazide may increase the hypoglycemic activities of Mecasermin.
Medrogestone
The serum concentration of Gliclazide can be decreased when it is combined with Medrogestone.
Medroxyprogesterone Acetate
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Medroxyprogesterone acetate.
Megestrol Acetate
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Megestrol acetate.
Mesalamine
Mesalazine may increase the hypoglycemic activities of Gliclazide.
Mesterolone
Mesterolone may increase the hypoglycemic activities of Gliclazide.
Mestranol
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Mestranol.
Metformin
Metformin may increase the hypoglycemic activities of Gliclazide.
Methotrimeprazine
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Methotrimeprazine.
Methyclothiazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Methyclothiazide.
Methyl Salicylate
Methyl salicylate may increase the hypoglycemic activities of Gliclazide.
Methylene blue
Methylene blue may increase the hypoglycemic activities of Gliclazide.
Methylprednisolone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Methylprednisolone.
Methyltestosterone
Methyltestosterone may increase the hypoglycemic activities of Gliclazide.
Metipranolol
Metipranolol may increase the hypoglycemic activities of Gliclazide.
Metolazone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Metolazone.
Metoprolol
Metoprolol may increase the hypoglycemic activities of Gliclazide.
Metreleptin
Metreleptin may increase the hypoglycemic activities of Gliclazide.
Miconazole
Miconazole may increase the hypoglycemic activities of Gliclazide.
Midostaurin
The metabolism of Gliclazide can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Gliclazide can be increased when it is combined with Mifepristone.
Miglitol
Miglitol may increase the hypoglycemic activities of Gliclazide.
Miglustat
Miglustat may increase the hypoglycemic activities of Gliclazide.
Milnacipran
Milnacipran may increase the hypoglycemic activities of Gliclazide.
Minaprine
Minaprine may increase the hypoglycemic activities of Gliclazide.
Moclobemide
The metabolism of Gliclazide can be decreased when combined with Moclobemide.
Modafinil
The metabolism of Gliclazide can be decreased when combined with Modafinil.
Nadolol
Nadolol may increase the hypoglycemic activities of Gliclazide.
Nalidixic Acid
Nalidixic Acid may increase the hypoglycemic activities of Gliclazide.
Nandrolone
Nandrolone may increase the hypoglycemic activities of Gliclazide.
Nandrolone Decanoate
Nandrolone decanoate may increase the hypoglycemic activities of Gliclazide.
Nateglinide
Nateglinide may increase the hypoglycemic activities of Gliclazide.
Nebivolol
Nebivolol may increase the hypoglycemic activities of Gliclazide.
Nefazodone
Nefazodone may increase the hypoglycemic activities of Gliclazide.
Nelfinavir
The metabolism of Gliclazide can be decreased when combined with Nelfinavir.
Niacin
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Niacin.
Nialamide
Nialamide may increase the hypoglycemic activities of Gliclazide.
Nicardipine
The metabolism of Gliclazide can be decreased when combined with Nicardipine.
Nilotinib
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Nilotinib.
Norethindrone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Norethisterone.
Norfloxacin
Norfloxacin may increase the hypoglycemic activities of Gliclazide.
Norgestimate
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Norgestimate.
Octreotide
Octreotide may increase the hypoglycemic activities of Gliclazide.
Olanzapine
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Olanzapine.
Olsalazine
Olsalazine may increase the hypoglycemic activities of Gliclazide.
Omeprazole
The metabolism of Gliclazide can be decreased when combined with Omeprazole.
Oxandrolone
Oxandrolone may increase the hypoglycemic activities of Gliclazide.
Oxprenolol
Oxprenolol may increase the hypoglycemic activities of Gliclazide.
Oxymetholone
Oxymetholone may increase the hypoglycemic activities of Gliclazide.
Paliperidone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Paliperidone.
Pantoprazole
The metabolism of Gliclazide can be decreased when combined with Pantoprazole.
Pargyline
Pargyline may increase the hypoglycemic activities of Gliclazide.
Paroxetine
Paroxetine may increase the hypoglycemic activities of Gliclazide.
Pasireotide
Gliclazide may increase the hypoglycemic activities of Pasireotide.
Pefloxacin
Pefloxacin may increase the hypoglycemic activities of Gliclazide.
Pegvisomant
Pegvisomant may increase the hypoglycemic activities of Gliclazide.
Penbutolol
Penbutolol may increase the hypoglycemic activities of Gliclazide.
Pentamidine
Pentamidine may increase the hypoglycemic activities of Gliclazide.
Phenelzine
Phenelzine may increase the hypoglycemic activities of Gliclazide.
Phenformin
Phenformin may increase the hypoglycemic activities of Gliclazide.
Phenindione
Gliclazide may increase the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Gliclazide can be increased when combined with Phenobarbital.
Phenprocoumon
Gliclazide may increase the anticoagulant activities of Phenprocoumon.
Phenytoin
The metabolism of Gliclazide can be increased when combined with Phenytoin.
Pindolol
Pindolol may increase the hypoglycemic activities of Gliclazide.
Pioglitazone
Pioglitazone may increase the hypoglycemic activities of Gliclazide.
Piperazine
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Piperazine.
Pipothiazine
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Pipotiazine.
Polythiazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Polythiazide.
Practolol
Practolol may increase the hypoglycemic activities of Gliclazide.
Pramlintide
Pramlintide may increase the hypoglycemic activities of Gliclazide.
Prednisolone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Prednisolone.
Prednisone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Prednisone.
Pregabalin
The risk or severity of heart failure can be increased when Pregabalin is combined with Gliclazide.
Primidone
The metabolism of Gliclazide can be increased when combined with Primidone.
Probenecid
The protein binding of Gliclazide can be decreased when combined with Probenecid.
Procarbazine
Procarbazine may increase the hypoglycemic activities of Gliclazide.
Progesterone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Progesterone.
Propranolol
Propranolol may increase the hypoglycemic activities of Gliclazide.
Pyrimethamine
The metabolism of Gliclazide can be decreased when combined with Pyrimethamine.
Quetiapine
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Quetiapine.
Quetiapine fumarate
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Quetiapine.
Quinethazone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Quinethazone.
Quinine
The metabolism of Gliclazide can be decreased when combined with Quinine.
Ranitidine
The serum concentration of Gliclazide can be increased when it is combined with Ranitidine.
Rasagiline
Rasagiline may increase the hypoglycemic activities of Gliclazide.
Regular Insulin, Human
Insulin Human may increase the hypoglycemic activities of Gliclazide.
Repaglinide
Repaglinide may increase the hypoglycemic activities of Gliclazide.
Rifampin
The serum concentration of Gliclazide can be decreased when it is combined with Rifampicin.
Rifapentine
The metabolism of Gliclazide can be increased when combined with Rifapentine.
Risperidone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Risperidone.
Ritonavir
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Ritonavir.
Rosiglitazone
Rosiglitazone may increase the hypoglycemic activities of Gliclazide.
Rosoxacin
Rosoxacin may increase the hypoglycemic activities of Gliclazide.
Rucaparib
The metabolism of Gliclazide can be decreased when combined with Rucaparib.
Salicylic Acid
Salicylic acid may increase the hypoglycemic activities of Gliclazide.
Saquinavir
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Saquinavir.
Saquinavir Mesylate
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Saquinavir.
Saxagliptin
Saxagliptin may increase the hypoglycemic activities of Gliclazide.
Saxagliptin Anhydrous
Saxagliptin may increase the hypoglycemic activities of Gliclazide.
Secobarbital
The metabolism of Gliclazide can be increased when combined with Secobarbital.
Selegiline
Selegiline may increase the hypoglycemic activities of Gliclazide.
Sertraline
The metabolism of Gliclazide can be decreased when combined with Sertraline.
Sildenafil
The metabolism of Gliclazide can be decreased when combined with Sildenafil.
Sirolimus
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Sirolimus.
Sitagliptin
Sitagliptin may increase the hypoglycemic activities of Gliclazide.
Sitagliptin Phosphate
Sitagliptin may increase the hypoglycemic activities of Gliclazide.
Sorafenib
The metabolism of Gliclazide can be decreased when combined with Sorafenib.
Sotalol
Sotalol may increase the hypoglycemic activities of Gliclazide.
Sparfloxacin
Sparfloxacin may increase the hypoglycemic activities of Gliclazide.
Stanozolol
Stanozolol may increase the hypoglycemic activities of Gliclazide.
Sulfadiazine
The metabolism of Gliclazide can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Gliclazide can be decreased when combined with Sulfamethoxazole.
Sulfisoxazole
The metabolism of Gliclazide can be decreased when combined with Sulfisoxazole.
Sunitinib
Gliclazide may increase the hypoglycemic activities of Sunitinib.
Tacrolimus
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Tacrolimus.
Talinolol
Talinolol may increase the hypoglycemic activities of Gliclazide.
Temafloxacin
Temafloxacin may increase the hypoglycemic activities of Gliclazide.
Temsirolimus
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Temsirolimus.
Testosterone
Testosterone may increase the hypoglycemic activities of Gliclazide.
Testosterone Cypionate
Testosterone cypionate may increase the hypoglycemic activities of Gliclazide.
Testosterone Enanthate
Testosterone enanthate may increase the hypoglycemic activities of Gliclazide.
Testosterone Propionate
Testosterone propionate may increase the hypoglycemic activities of Gliclazide.
Testosterone Undecanoate
Testosterone undecanoate may increase the hypoglycemic activities of Gliclazide.
Thioctic Acid
Lipoic Acid may increase the hypoglycemic activities of Gliclazide.
Ticagrelor
The metabolism of Gliclazide can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Gliclazide can be decreased when combined with Ticlopidine.
Timolol
Timolol may increase the hypoglycemic activities of Gliclazide.
Timolol Anhydrous
Timolol may increase the hypoglycemic activities of Gliclazide.
Tipranavir
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Tipranavir.
Tolazamide
Tolazamide may increase the hypoglycemic activities of Gliclazide.
Tolbutamide
The metabolism of Gliclazide can be decreased when combined with Tolbutamide.
Toloxatone
Toloxatone may increase the hypoglycemic activities of Gliclazide.
Topiramate
The metabolism of Gliclazide can be decreased when combined with Topiramate.
Torsemide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Torasemide.
Tranylcypromine
The metabolism of Gliclazide can be decreased when combined with Tranylcypromine.
Triamcinolone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Triamcinolone.
Trichlormethiazide
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Trichlormethiazide.
Trimethoprim
The metabolism of Gliclazide can be decreased when combined with Trimethoprim.
Triptorelin
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Triptorelin.
Troglitazone
Troglitazone may increase the hypoglycemic activities of Gliclazide.
Trolamine Salicylate
Trolamine salicylate may increase the hypoglycemic activities of Gliclazide.
Trovafloxacin
Trovafloxacin may increase the hypoglycemic activities of Gliclazide.
Valproate
The metabolism of Gliclazide can be decreased when combined with Valproic Acid.
Valproic Acid
The metabolism of Gliclazide can be decreased when combined with Valproic Acid.
Valsartan
The metabolism of Gliclazide can be decreased when combined with Valsartan.
Venlafaxine
Venlafaxine may increase the hypoglycemic activities of Gliclazide.
Vildagliptin
Vildagliptin may increase the hypoglycemic activities of Gliclazide.
Voriconazole
The serum concentration of Gliclazide can be increased when it is combined with Voriconazole.
Vorinostat
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Vorinostat.
Warfarin
Gliclazide may increase the anticoagulant activities of Warfarin.
Zafirlukast
The metabolism of Gliclazide can be decreased when combined with Zafirlukast.
Ziprasidone
The therapeutic efficacy of Gliclazide can be decreased when used in combination with Ziprasidone.
